347 related articles for article (PubMed ID: 12920414)
21. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
22. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
23. Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification.
Liappas J; Paparrigopoulos T; Tzavellas E; Rabavilas A
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):55-60. PubMed ID: 15610945
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of indiplon in older adults with primary insomnia.
Walsh JK; Moscovitch A; Burke J; Farber R; Roth T
Sleep Med; 2007 Nov; 8(7-8):753-9. PubMed ID: 17825616
[TBL] [Abstract][Full Text] [Related]
25. Effects of alcohol on polysomnographically recorded sleep in healthy subjects.
Feige B; Gann H; Brueck R; Hornyak M; Litsch S; Hohagen F; Riemann D
Alcohol Clin Exp Res; 2006 Sep; 30(9):1527-37. PubMed ID: 16930215
[TBL] [Abstract][Full Text] [Related]
26. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double-blind randomized clinical trial.
Peles E; Hetzroni T; Bar-Hamburger R; Adelson M; Schreiber S
Addiction; 2007 Dec; 102(12):1947-53. PubMed ID: 17916225
[TBL] [Abstract][Full Text] [Related]
27. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
28. Trazodone, a triazolopyridine derivative, in primary depressive disorder.
Feighner JP
J Clin Psychiatry; 1980 Jul; 41(7):250-5. PubMed ID: 6993447
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
[TBL] [Abstract][Full Text] [Related]
30. Effect of trazodone in a single dose before bedtime for sleep disorders accompanied by a depressive state: dose-finding study with no concomitant use of hypnotic agent.
Mashiko H; Niwa S; Kumashiro H; Kaneko Y; Suzuki S; Numata Y; Horikoshi R; Watanabe Y
Psychiatry Clin Neurosci; 1999 Apr; 53(2):193-4. PubMed ID: 10459686
[TBL] [Abstract][Full Text] [Related]
31. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
32. Clonazepam: sleep laboratory study of efficacy and withdrawal.
Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
[TBL] [Abstract][Full Text] [Related]
33. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
34. Ramelteon for the treatment of insomnia.
Borja NL; Daniel KL
Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
[TBL] [Abstract][Full Text] [Related]
35. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults.
Ware JC; Pittard JT
J Clin Psychiatry; 1990 Sep; 51 Suppl():18-22. PubMed ID: 2211560
[TBL] [Abstract][Full Text] [Related]
36. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.
Jacobs GD; Pace-Schott EF; Stickgold R; Otto MW
Arch Intern Med; 2004 Sep; 164(17):1888-96. PubMed ID: 15451764
[TBL] [Abstract][Full Text] [Related]
37. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients.
Saletu-Zyhlarz GM; Anderer P; Arnold O; Saletu B
Neuropsychobiology; 2003; 48(4):194-208. PubMed ID: 14673218
[TBL] [Abstract][Full Text] [Related]
38. Trazodone in burning mouth pain: a placebo-controlled, double-blind study.
Tammiala-Salonen T; Forssell H
J Orofac Pain; 1999; 13(2):83-8. PubMed ID: 10425979
[TBL] [Abstract][Full Text] [Related]
39. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
